#BEGIN_DRUGCARD DB06727

# AHFS_Codes:
Not Available

# ATC_Codes:
C01BA04

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Aurumheel (Arnica + Convallaria Majalis + Hawthorn + Sodium Tetrachloroaurate(Iii) + Sparteine + Valerian)

# Brand_Names:
Not Available

# CAS_Registry_Number:
90-39-1

# ChEBI_ID:
28827

# Chemical_Formula:
C15H26N2

# Chemical_IUPAC_Name:
(1S,2S,9S,10S)-7,15-diazatetracyclo[7.7.1.0^{2,7}.0^{10,15}]heptadecane

# Chemical_Structure:
Not Available

# Creation_Date:
2010-08-18 14:01:11 -0600

# DPD_Drug_ID_Number:
1970631

# Description:
Sparteine is a class 1a antiarrhythmic agent; a sodium channel blocker. It is an alkaloid and can be extracted from scotch broom. It is the predominant alkaloid in Lupinus mutabilis, and is thought to chelate the bivalents calcium and magnesium. It is not FDA approved for human use as an antiarrhythmic agent, and it is not included in the Vaughn Williams classification of antiarrhythmic drugs.

# Dosage_Forms:
Not Available

# Drug_Category:
Antiarrhythmic Agents
Oxytocics

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
3040 mg/L (at 22 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Sparteine

# HET_ID:
Not Available

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C15H26N2/c1-3-7-16-11-13-9-12(14(16)5-1)10-17-8-4-2-6-15(13)17/h12-15H,1-11H2/t12-,13-,14-,15-/m0/s1

# InChI_Key:
InChIKey=SLRCCWJSBJZJBV-AJNGGQMLSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C10783

# KEGG_Drug_ID:
D01041

# LIMS_Drug_ID:
6733

# Mechanism_Of_Action:
Not Available

# Melting_Point:
30.5 °C

# Molecular_Weight_Avg:
234.3803

# Molecular_Weight_Mono:
234.209598842

# Organisms_Affected:
Humans and other mammals

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
PA452610

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
2.98

# Predicted_LogS:
-2.4

# Predicted_Water_Solubility:
9.31e-01 g/l

# Primary_Accession_No:
DB06727

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46937024

# PubChem_Substance_ID:
99443273

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@@H]34)[C@@H]2C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
(-)-sparteine
Esparteina
Genisteine
Pachycarpine
Sparteinum
Sparteinum sulfuricum
d-Sparteine
lupinidine

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:24:50 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Sparteine

# pKa_Isoelectric_Point:
Not Available

# Phase_1_Metabolizing_Enzyme_1_Gene_Name:
CYP2D6

# Phase_1_Metabolizing_Enzyme_1_ID:
4119

# Phase_1_Metabolizing_Enzyme_1_Name:
Cytochrome P450 2D6

# Phase_1_Metabolizing_Enzyme_1_Protein_Sequence:
>Cytochrome P450 2D6
MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQ
LRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVF
LARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDK
AVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKV
LRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVA
DLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVI
HEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHF
LDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGV
FAFLVSPSPYELCAVPR

# Phase_1_Metabolizing_Enzyme_1_SwissProt_ID:
P10635

#END_DRUGCARD DB06727
